Teva CEO Schultz To Sign On For Another Year
Schultz Set For At Least Six Years As Teva’s CEO
Teva CEO Kåre Schultz has received full backing to add another year onto his five-year contract, with a significant rise in compensation available if Teva’s shareholders say so later this year.
